Prestige Consumer Healthcare Inc. (PBH:NYSE) closed at $47.80 on October 23, 2026, down 3.36% on the day. The stock trades 32.7% below its 52-week high of $71.07 and 12.2% above its 52-week low of $42.62. Over the past year, it lost 23.2%. Prestige Consumer Healthcare Inc. is part of the Health Care sector (Major Pharmaceuticals).
In 252 trading sessions since October 23, 2025, PBH closed higher on 125 days (50%). Its best day was April 6, 2026 (+5.05%) and its worst was May 14, 2026 (-11.35%). The stock moved 10% or more in a single session 1 time.
Prestige Brands Holdings, Inc., through its subsidiaries, markets, sells, and distributes over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates through North American OTC Healthcare, International OTC Healthcare, and Household Cleaning segments. The company's OTC healthcare products portfolio include such as Chloraseptic sore throat treatments, Clear Eyes eye care products, Compound W wart removers, Dramamine Non-Drowsy naturals, Efferdent denture cleansers, Little Remedies pediatric products, Luden's throat drops, The Doctor's brand of oral care products, BC and Goody's analgesic powders, Beano gas prevention, Debrox ear wax removals, and Gaviscon upset stomach remedies. Its OTC healthcare products portfolio also comprise Dermoplast first-aid products, New-Skin liquid bandages, Fess nasal saline spray, Hydralyte for dehydration and electrolyte replacement, Monistat for vaginal treatment-anti-fungal, e.p.t family planning products, Ecotrin aspirin, Nix lice/parasite treatments, DenTek for peg oral care, and Uristat urinary tract infection treatments. The company also offers household cleaning products consist...
Find more stocks like PBH with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.